Mark R. Wallace

7.3k total citations · 1 hit paper
131 papers, 5.3k citations indexed

About

Mark R. Wallace is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Mark R. Wallace has authored 131 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Epidemiology, 56 papers in Infectious Diseases and 38 papers in Virology. Recurrent topics in Mark R. Wallace's work include HIV Research and Treatment (32 papers), HIV/AIDS Research and Interventions (18 papers) and Herpesvirus Infections and Treatments (14 papers). Mark R. Wallace is often cited by papers focused on HIV Research and Treatment (32 papers), HIV/AIDS Research and Interventions (18 papers) and Herpesvirus Infections and Treatments (14 papers). Mark R. Wallace collaborates with scholars based in United States, Canada and Egypt. Mark R. Wallace's co-authors include Nancy F. Crum, Sybil Tasker, Edward C. Oldfield, Igor Grant, Stephanie K. Brodine, Scott A. Wegner, Susan Fraser, Brian K. Agan, Ronald J. Ellis and Katherine Spooner and has published in prestigious journals such as JAMA, The Journal of Experimental Medicine and Annals of Internal Medicine.

In The Last Decade

Mark R. Wallace

128 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The HNRC 500-Neuropsychology of Hiv infection at different disease stages

1995 543 citations Mark R. Wallace et al. profile →

Peers

Countries citing papers authored by Mark R. Wallace

Since Specialization

Citations

This map shows the geographic impact of Mark R. Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Wallace more than expected).

Fields of papers citing papers by Mark R. Wallace

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Wallace. The network helps show where Mark R. Wallace may publish in the future.

Co-authorship network of co-authors of Mark R. Wallace

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Wallace. A scholar is included among the top collaborators of Mark R. Wallace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Wallace. Mark R. Wallace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Comparison of Perceived Lifetime Breast Cancer Risk to Calculated Lifetime Risk Using the Gail Risk Assessment Tool 2022 ·Journal of Women s Health ·Jaya Mehta, Kathy L. MacLaughlin, Denise Millstine, Stephanie S. Faubion, Mark R. Wallace, Amit Shah, (unknown), (unknown), Michael Bryan, Bhavika Patel, Matthew Buras, Michael A. Golafshar, Juliana M. Kling	2
2	Vaccination in HIV-Infected Adults 2014 ·AIDS Patient Care and STDs ·Nancy F. Crum‐Cianflone, Mark R. Wallace	53
3	Daptomycin non-susceptible Staphylococcus aureus at a US medical centre 2013 ·Clinical Microbiology and Infection ·(unknown), C Andrew DeRyke, Richard V. Goering, (unknown), Mark R. Wallace	9
4	The impact of initial antibiotic therapy (linezolid, vancomycin, daptomycin) on hospital length of stay for complicated skin and soft tissue infections 2013 ·SpringerPlus ·(unknown), (unknown), (unknown), C Andrew DeRyke, (unknown), Mark R. Wallace	3
5	Gordonia bronchialis Sternal Wound Infection in 3 Patients following Open Heart Surgery: Intraoperative Transmission from a Healthcare Worker 2012 ·Infection Control and Hospital Epidemiology ·(unknown), (unknown), (unknown), (unknown), Steven G. McNulty, Scott A. Brown, (unknown), (unknown), Mark R. Wallace	38
6	Case Report: Cryptococcal Meningitis Manifesting as a Large Abdominal Cyst in a HIV-Infected Patient with a CD4 Count Greater than 400 cells/mm ³ 2008 ·AIDS Patient Care and STDs ·Nancy F. Crum‐Cianflone, (unknown), Mark R. Wallace	4
7	Erectile Dysfunction and Hypogonadism among Men with HIV 2007 ·AIDS Patient Care and STDs ·Nancy F. Crum‐Cianflone, Mary Bavaro, Braden Hale, Christopher L. Amling, (unknown), Carolyn Brandt, (unknown), (unknown), Sheila Medina, Mark R. Wallace	105
8	Comparisons of Causes of Death and Mortality Rates Among HIV-Infected Persons 2006 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Nancy F. Crum, Robert H. Riffenburgh, Scott A. Wegner, Brian K. Agan, Sybil Tasker, Katherine Spooner, Adam W. Armstrong, Susan Fraser, Mark R. Wallace	387
9	New issues in infectious diarrhea. 2005 ·PubMed ·(unknown), Mark R. Wallace, Edward C. Oldfield	3
10	A Review of Hypogonadism and Erectile Dysfunction Among HIV-Infected Men During the Pre- and Post-HAART Eras: Diagnosis, Pathogenesis, and Management 2005 ·AIDS Patient Care and STDs ·Nancy F. Crum, (unknown), Patrick E. Olson, Christopher L. Amling, Mark R. Wallace	60
11	A Review of Hypogonadism and Erectile Dysfunction Among HIV-Infected Men During the Pre- and Post-HAART Eras: Diagnosis, Pathogenesis, and Management 2005 ·AIDS Patient Care and STDs ·Nancy F. Crum, (unknown), Patrick E. Olson, Christopher L. Amling, Mark R. Wallace	5
12	Evidence of Human Herpesvirus 6 Infection in 4 Immunocompetent Patients with Encephalitis 2005 ·Clinical Infectious Diseases ·Erin Isaacson, Carol Glaser, Bagher Forghani, (unknown), Mark R. Wallace, Robert W. Armstrong, Maurice M. Exner, Scott Schmid	77
13	The Changing Economics of HIV Care 2001 ·AIDS Patient Care and STDs ·Mark R. Wallace, Sybil Tasker, (unknown), (unknown), Gail D. Chapman, (unknown)	9
14	Enhancement of HIV Type 1 Antigen-Specific CD4 ⁺ T Cell Memory in Subjects with Chronic HIV Type 1 Infection Receiving an HIV Type 1 Immunogen 2000 ·AIDS Research and Human Retroviruses ·Vernon C. Maino, Maria Suni, Susan B. Wormsley, Dennis J. Carlo, Mark R. Wallace, Ronald B. Moss	37
15	Fatal Group B Streptococcal Meningitis in a Previously Healthy Young Adult 1999 ·Clinical Infectious Diseases ·(unknown), Alexander J. Kallen, Mark R. Wallace	12
16	Cross-Clade Immune Responses after Immunization with a Whole-Killed gp120-Depleted Human Immunodeficiency Virus Type-1 Immunogen in Incomplete Freund's Adjuvant (HIV-1 Immunogen, Remune™) in Human Immunodeficiency Virus Type-1 Seropositive Subjects 1997 ·Viral Immunology ·Ronald B. Moss, Wieslawa Giermakowska, Paola Lanza, John L. Turner, Mark R. Wallace, Fred C. Jensen, Georgia Theofan, Steven P. Richieri, Dennis J. Carlo	24
17	Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: Evidence for frequent serologic relapse after therapy 1995 ·The American Journal of Medicine ·Joseph L. Malone, Mark R. Wallace, (unknown), (unknown), (unknown), Stephanie K. Brodine, William A. Bowler, Bruce Lavin, Richard E. Hawkins, Edward C. Oldfield	87
18	Threat of Hepatitis E Virus Infection in Somalia During Operation Restore Hope 1994 ·Clinical Infectious Diseases ·James P. Burans, (unknown), Mark R. Wallace, Charles F. Longer, Scott A. Thornton, Roger A. Batchelor, Vera Clemens, Kenneth C. Hyams	25
19	Quantitation of HIV Viral Burden by PCR in HIV Seropositive Navy Personnel Representing Walter Reed Stages 1 to 6 1992 ·AIDS Research and Human Retroviruses ·F. Ferré, (unknown), (unknown), D E Lewis, Mark R. Wallace, H. James Beecham, Karen G. Burnett, Fred C. Jensen, Dennis J. Carlo	30
20	Tracheobronchitis Due to Corynebacterium pseudodiphtheriticum 1991 ·Southern Medical Journal ·Timothy Craig, (unknown), Mark R. Wallace	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact